Finance

Lists
Why is 300261 down 2,27%?
Dive Deeper
300261:SHE
ABA Chemicals Corp
CNÂ¥4,74
-2,27%
(-0,11) 1D
14 Okt., 15:04:40 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300261...
Open
CNÂ¥4,82
High
CNÂ¥4,87
Low
CNÂ¥4,73
Mkt. cap
4,66 mjd
Avg. vol.
14,00 m
Volume
6,59 m
52-wk high
CNÂ¥8,66
52-wk low
CNÂ¥4,27
EPS
-CNÂ¥0,33
Shares outstanding
963,31 m
No. of employees
1 k
Open
CNÂ¥4,82
High
CNÂ¥4,87
Low
CNÂ¥4,73
Mkt. cap
4,66 mjd
Avg. vol.
14,00 m
Volume
6,59 m
52-wk high
CNÂ¥8,66
52-wk low
CNÂ¥4,27
EPS
-CNÂ¥0,33
Shares outstanding
963,31 m
No. of employees
1 k
News stories
From web sources and news partners
Profile
ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261. The company provides contract development and manufacturing services to the pharmaceutical, biotechnological, and agrochemical industries. It offers various services for the production of fine chemicals; intermediates; and active pharmaceutical ingredients. The company also provides unnatural amino acids, pyrazoles, triazoles, and azaindoles, as well as producing an intermediate of API Levetiracetam for the treatment of epilepsy. The company is also involved in pesticide manufacturing intermediates, and acquired the Chinese firm Shanghai Puyi Chemical to consolidate its position in this market. It also acquired Amino Chemicals, a pharmaceutical API intermediate manufacturer and member of the Dipharma Group, in 2017; Amino is based on Malta and was established in 1992. ABA and Dipharma began a working partnership in the 1980s, which provided Dipharma access to the Chinese pharmaceutical market. Wikipedia
About ABA Chemicals Corp
CEO-
Employees1,2 k
Founded13 Jan. 2006
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
334,69 m
310,82 m
303,59 m
293,25 m
Cost of goods sold
248,45 m
300,89 m
286,91 m
289,14 m
Cost of revenue
248,45 m
300,89 m
286,91 m
289,14 m
Research and development expenses
29,18 m
28,68 m
20,19 m
22,86 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48,48 m
37,47 m
41,02 m
41,59 m
Operating expense
81,42 m
103,89 m
62,77 m
66,53 m
Total operating expenses
329,87 m
404,78 m
349,68 m
355,67 m
Operating income
4,82 m
-93,96 m
-46,09 m
-62,42 m
Other non operating income
15,52 m
-16,13 m
-10,85 m
9,81 m
EBT including unusual items
-2,79 m
-177,93 m
-73,15 m
-115,16 m
EBT excluding unusual items
-1,61 m
-124,19 m
-66,74 m
-83,81 m
Income tax expense
-3,44 m
-6,13 m
-14,24 m
-13,04 m
Effective tax rate
123,57%
3,45%
19,47%
11,32%
Other operating expenses
2,79 m
-849,91 k
2,71 m
3,05 m
Net income
1,75 m
-152,59 m
-57,58 m
-101,81 m
Net profit margin
0,52%
-49,09%
-18,97%
-34,72%
Earnings per share
-
-
-
-
Interest and investment income
5,04 m
-
568,87 k
77,43 k
Interest expense
-9,72 m
-15,90 m
-10,37 m
-13,65 m
Net interest expenses
-4,68 m
-15,90 m
-9,80 m
-13,58 m
Depreciation and amortization charges
-
-
-
-
EBITDA
38,18 m
-59,20 m
-11,33 m
-28,50 m
Gain or loss from assets sale
110,13 k
-161,52 k
-
-258,93 k
AI content may include mistakes. Learn more
Google-programme